N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide

C48H59N7O7 — CID 168983743

IUPACN-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide
SMILESC=CC(=O)N1CC(NCC(C(=O)NC2Cc3cc(O)cc(c3)-c3ccc4c(c3)c(c(-c3cccnc3COC)n4CC)CC(C)(C)COC(=O)[C@@H]3CCCN(N3)C2=O)=C(C)C)C1
InChIInChI=1S/C48H59N7O7/c1-8-43(57)53-25-33(26-53)50-24-38(29(3)4)45(58)51-40-20-30-18-32(21-34(56)19-30)31-14-15-42-36(22-31)37(44(54(42)9-2)35-12-10-16-49-41(35)27-61-7)23-48(5,6)28-62-47(60)39-13-11-17-55(52-39)46(40)59/h8,10,12,14-16,18-19,21-22,33,39-40,50,52,56H,1,9,11,13,17,20,23-28H2,2-7H3,(H,51,58)/t39-,40?/m0/s1
InChIKeySTLDGPLLGGKVJV-KLBOFATRSA-N
MW846.04 g/mol
LogP5.21
Rot. Bonds10

About N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide

N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide (PubChem CID 168983743) has the molecular formula C48H59N7O7 and a molecular weight of 846.04 g/mol. Its IUPAC name is N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide.

Molecular Properties

Compound NameN-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide
PubChem CID168983743
Molecular FormulaC48H59N7O7
Molecular Weight846.04 g/mol
Exact Mass845.45
IUPAC NameN-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide
SMILESC=CC(=O)N1CC(NCC(C(=O)NC2Cc3cc(O)cc(c3)-c3ccc4c(c3)c(c(-c3cccnc3COC)n4CC)CC(C)(C)COC(=O)[C@@H]3CCCN(N3)C2=O)=C(C)C)C1
InChIInChI=1S/C48H59N7O7/c1-8-43(57)53-25-33(26-53)50-24-38(29(3)4)45(58)51-40-20-30-18-32(21-34(56)19-30)31-14-15-42-36(22-31)37(44(54(42)9-2)35-12-10-16-49-41(35)27-61-7)23-48(5,6)28-62-47(60)39-13-11-17-55(52-39)46(40)59/h8,10,12,14-16,18-19,21-22,33,39-40,50,52,56H,1,9,11,13,17,20,23-28H2,2-7H3,(H,51,58)/t39-,40?/m0/s1
InChIKeySTLDGPLLGGKVJV-KLBOFATRSA-N
XLogP5.21
TPSA167.36 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds10
Heavy Atoms62
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500846.04
LogP ≤ 55.21
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide?
The IUPAC name of N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide (CID 168983743) is N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide.
What is the SMILES notation for N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide?
The canonical SMILES for N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide is C=CC(=O)N1CC(NCC(C(=O)NC2Cc3cc(O)cc(c3)-c3ccc4c(c3)c(c(-c3cccnc3COC)n4CC)CC(C)(C)COC(=O)[C@@H]3CCCN(N3)C2=O)=C(C)C)C1.
What is the InChIKey of N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide?
The InChIKey is STLDGPLLGGKVJV-KLBOFATRSA-N. The full InChI is InChI=1S/C48H59N7O7/c1-8-43(57)53-25-33(26-53)50-24-38(29(3)4)45(58)51-40-20-30-18-32(21-34(56)19-30)31-14-15-42-36(22-31)37(44(54(42)9-2)35-12-10-16-49-41(35)27-61-7)23-48(5,6)28-62-47(60)39-13-11-17-55(52-39)46(40)59/h8,10,12,14-16,18-19,21-22,33,39-40,50,52,56H,1,9,11,13,17,20,23-28H2,2-7H3,(H,51,58)/t39-,40?/m0/s1.
What are the key properties of N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide?
N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide has a molecular weight of 846.04 g/mol, XLogP of 5.21, 10 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(14S)-22-ethyl-4-hydroxy-21-[2-(methoxymethyl)-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-3-methyl-2-[[(1-prop-2-enoylazetidin-3-yl)amino]methyl]but-2-enamide is sourced from PubChem (CID 168983743), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).